Retort & Aseptic Package Patents: Leaders & Filing Trends 2026
- 48.0% concentration. The top 5 of 77 ranked assignees hold 228 of 475 records in scope — a field with a clear head and a long tail of single-digit filers.
- Filings down 61%. From 38 records in 2021 to 15 in 2024, the complete-year data shows the field cooling from its 2019 peak of 39.
- Laminates dominate claim space. B32B layered-products claims sit on 72.6% of all 475 records — the densest single technology bucket in this dataset.
Filing growth compares 2021 (38 records) with 2024 (15) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 475 records in scope (CR5), not by the ranked leaders only.
What this landscape covers
Retort and aseptic package sterilization sits at the intersection of barrier-film chemistry, seal engineering and validated thermal or chemical sterilization protocols. Patents in this space cover multilayer laminate structures, peelable lidding membranes, adhesive tie layers, and the sealing resins that must survive retort autoclaving or hydrogen peroxide sterilant exposure without delamination or package deformation. The 475 records in scope span filings from 2015 through the 2026 cut-off, drawn from assignees spread across food, nutrition and industrial packaging supply chains.
Publication lags filing by roughly 18 months, so the most recent one to two years in any trend understate actual filing activity. The complete-year data — through 2024 — is the more reliable basis for judging direction.
Let an AI agent run this analysis on your own technology
Pick a task. Every answer cites the patents behind it.
Filing trend and technology composition
Two views of the same 475 records: filing activity over time, and where those records sit across IPC subclasses. Because a single record can carry several IPC classes, the composition shares add up to more than 100% of the record total.
Filing trend, 2017-2026
Filings peaked at 39 in 2019, held near that level through 2021 at 38, then fell to 15 by 2024 — a decline of 61% over that three-year span. 2025 and 2026 figures are still filling in due to publication lag and should not be read as a continuation of the drop.
Technology composition by IPC subclass
B32B (layered products & laminates) appears in 72.6% of the 475 records, far ahead of B65D containers at 36.8% and C08L polymer compositions at 19.2%. The gap between B32B and every other subclass indicates most claim activity concentrates on the laminate structure itself rather than the container form or sterilization process.
Shares are the percentage of the 475 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Retort and Aseptic Package Sterilization with Eureka
This page is one run against one query. Ask Eureka your own question about retort and aseptic package sterilization and every answer comes back with the patent numbers behind it.
Try EurekaMost-cited records in this landscape
US7798359B1 — Heat-sealed, peelable lidding membrane for retort packaging
The membrane laminates a plastic layer to a foil layer with a first adhesive, then laminates a co-extruded layer to the foil with a second adhesive. The co-extruded layer combines a plastic body with a heat-sealable sealing resin layer, giving a peelable seal designed to survive retort processing.Assigned to Berry Plastics Corporation, published 2010-09-21.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US5346735A | Peelable barrier film for vacuum skin packages and the like | 188 |
| 2 | US20070264520A1 | Articles having a polymer grafted cyclodextrin | 168 |
| 3 | US5160767A | Peelable packaging and sheet materials and compositions for use therein | 119 |
| 4 | US4937139A | Peelable packaging and sheet materials and compositions for use therein | 103 |
| 5 | US7798359B1 | Heat-sealed, peelable lidding membrane for retort packaging | 77 |
| 6 | WO2014043522A1 | Multilayered polyolefin-based films | 64 |
| 7 | EP0761739A1 | Gas barrier resin composition and process for producing the same | 60 |
| 8 | US5854326A | Gas barrier resin composition and process for producing the same | 59 |
| 9 | US20080003390A1 | Multi-Layer Structure and Process for Production Thereof | 55 |
| 10 | US4308084A | Process for preparing retort-proof metal layer laminates for packaging foodstuffs using aluminum hydroxide-mo… | 54 |
Citation counts inside a searched corpus favour older records — treat them as a signal of influence on the field, not of current commercial relevance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the numbers mean for filing strategy
Concentration, citation patterns and receiving-office spread each point to a different part of the same story: claim space on the laminate structure is heavily occupied, while the sterilization process and container-form layers carry more room to move.
A short head, a long tail
Five assignees out of 77 ranked hold nearly half of all records in scope. The next five add another 90 records to reach 66.9% for the top 10 — after that, the ranking thins quickly into single- and double-digit filers.
Older peelable-film patents still anchor the field
The most-cited records date to the early 1990s and concern peelable barrier films and sheet materials generally, not retort-specific sterilant exposure. Their influence reflects breadth of prior art, not current filing activity.
Europe leads filing volume, not just the US
Receiving-office counts show EPO ahead of the United States, with WIPO PCT, Japan, India and Australia each contributing a meaningful but smaller share. This spread suggests validation-protocol and seal-integrity claims are being filed for multi-jurisdiction food-packaging supply chains, not a single home market.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to retort and aseptic package sterilization, with the prior art for and against each one.
Who holds the claims, and where activity has stalled
The ranked leaders in this dataset show heavy concentration at the top, but recent-year momentum has gone flat or negative across nearly every one of them — consistent with the broader post-2021 filing decline.
One assignee sits well ahead of fifth place
The leading assignee's 84 records compare to 30 at fifth place and 14 at tenth — a steep drop-off that marks this as a field with one dominant filer rather than a tight cluster at the top.
Even top filers show zero activity in the latest year
Multiple assignees among the ranked leaders recorded zero filings in the latest year, including year-over-year drops of -100% for some. Given publication lag, this reflects incomplete recent data as much as any deliberate pullback.
A small number of tight co-filing relationships
Ten co-assignee pairs appear in this dataset. The strongest pair shares 23 records, well ahead of the next strongest pairs at 10 and 8 — suggesting a small number of joint-development or supply relationships account for a disproportionate share of collaborative filing.
| Assignee | Recent year | YoY |
|---|---|---|
| Amcor Flexibles North America, Inc. | 0 | -100% |
| Dow Global Technologies LLC | 0 | -100% |
| Kuraray Co., Ltd. | 0 | — |
| Sealed Air Corporation | 0 | — |
| Cryovac, Inc. | 0 | — |
| Fuji Food Packaging Co., Ltd. | 0 | — |
| MJN US Holdings LLC | 0 | — |
| Abbott Laboratories, Inc. | 0 | — |
Where to take this analysis
The dataset points to specific next steps depending on whether the goal is freedom-to-operate, white-space scouting, or tracking a competitor.
Check freedom-to-operate against the laminate cluster
With B32B claims present on 72.6% of records, any new multilayer structure for retort or aseptic packaging should be checked against the leading assignee's portfolio before committing to a laminate architecture.
Run an FTO scan in EurekaScout the validation-protocol white space
Sterilant exposure validation and lethality value process claims show thinner density than the laminate and container classes, and may offer more room for a defensible first claim.
Explore white space in EurekaTrack leading-assignee activity as data fills in
Recent-year momentum figures are incomplete due to publication lag; revisit filing counts for the top assignees once 2025-2026 data matures.
Set up assignee tracking in EurekaCommon questions on this landscape
The dataset ranks 77 assignees across 475 records, with the leading assignee holding 84 records compared to 30 at fifth place and 14 at tenth. This steep drop-off means the field has one clearly dominant filer rather than a tight cluster of comparably sized competitors. The top 5 assignees combined hold 228 records, or 48.0% of all records in scope, and the top 10 hold 66.9%. Anyone assessing competitive risk in this space should look closely at the leader's portfolio first, since it accounts for a disproportionate share of claim coverage.
Complete-year data shows filings falling from 38 in 2021 to 15 in 2024, a 61% decline over that span, following a peak of 39 in 2019. This pattern is consistent with a maturing claim landscape where the core laminate and sealing-resin architectures are already well covered by existing patents. However, figures for 2025 and 2026 are still incomplete because publication typically lags actual filing by around 18 months, so the true recent trend cannot yet be read from the latest two years alone.
Layered products and laminates (IPC class B32B) appear in 72.6% of the 475 records in scope, making it by far the densest technology bucket, ahead of containers and packaging (B65D) at 36.8% and polymer compositions (C08L) at 19.2%. Because a single patent record can be classified under multiple IPC subclasses, these shares add up to more than 100% of the record total. The concentration in B32B indicates that most patent activity targets the multilayer film or membrane structure itself rather than the sterilization process or the container geometry.
US7798359B1, assigned to Berry Plastics Corporation and published in 2010, claims a heat-sealed, peelable lidding membrane built from a plastic layer laminated to a foil layer, with a co-extruded layer carrying its own heat-sealable sealing resin bonded on with a second adhesive. Any new lidding membrane that uses this same foil-plastic-adhesive-coextrusion stack for retort applications should be checked against its specific claim language before proceeding. It does not, by itself, block every peelable seal design — alternatives using different adhesive chemistries, non-foil barrier layers, or different lamination sequences may sit outside its claims, but that requires a specific claim-by-claim comparison.
The technology composition data shows heavy claim density on laminate structures (B32B, 72.6% of records) and containers (B65D, 36.8%), but comparatively thinner coverage on the sterilization validation side — areas like hydrogen peroxide sterilant exposure validation, lethality value process control, and package deformation detection. These branches appear in the search criteria but do not dominate the IPC composition, suggesting claims on the validation protocol and process-control side of sterilization are less crowded than claims on the film and container structures themselves. A first claim in these areas would need to tie a specific measurable parameter — such as a validated lethality threshold or a deformation detection method — to a defined packaging format.
Research Retort and Aseptic Package Sterilization in depth with Eureka
Go past this page: query the whole retort and aseptic package sterilization corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.